Industry: Medical Devices & Consumables
Published Date: 2026-04-17
Pages: 126 Pages
Report ld: 6468570
Request Sample
Customized Report
The global Neonatal Phototherapy Units market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Neonatal Phototherapy Units competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Jaundice (Hyperbilirubinemia) is a common condition, particularly in pre-mature babies worldwide. The skin of the newborn baby becomes jaundiced (baby’s skin and Sclerae appear yellow) which is caused by a high level of bilirubin in the blood. Bilirubin is a waste product, produced when red blood cells are broken down. It is normally broken down in the liver and removed from the body in the stool. However, an underdeveloped liver of infant cannot filter out the bilirubin as fast as it i being produced, resulting in hyperbilirubinemia (Jaundice). If untreated the levels of bilirubin may rise high enough to pass through the blood brain barrier and is deposited in the brain causing Kernicterus and brain damage. Phototherapy is a treatment with special type of light (wavelength range 420 to 480nm) which lower bilirubin level in neonatal, the process is called photo-oxidation in which light wave converts the bilirubin to water soluble non-toxic form, make it easier for baby’s liver to break down and remove the bilirubin from their blood.
The North American market for Neonatal Phototherapy Units is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Neonatal Phototherapy Units is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Neonatal Phototherapy Units include GE Healthcare, Weyer GmbH, Delta Medical International, Natus Medical Incorporated, Medicor, Drager, Zeal Medical, MTTS, David Medical Device, BEING MEDICAL DEVICE, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Neonatal Phototherapy Units market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Neonatal Phototherapy Units. The Neonatal Phototherapy Units market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Neonatal Phototherapy Units market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Neonatal Phototherapy Units manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Neonatal Phototherapy Units manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Neonatal Phototherapy Units sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Neonatal Phototherapy Units Market Overview
1.1 Product Definition
1.2 Neonatal Phototherapy Units by Type
1.2.1 Global Neonatal Phototherapy Units Market Value by Type: 2025 vs 2032
1.2.2 Single Surface Phototherapy Units
1.2.3 Double Surface Phototherapy Units
1.3 Neonatal Phototherapy Units by Application
1.3.1 Global Neonatal Phototherapy Units Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Confinement Centers
1.3.4 Others
1.4 Global Neonatal Phototherapy Units Market Size Estimates and Forecasts
1.4.1 Global Neonatal Phototherapy Units Revenue 2021–2032
1.4.2 Global Neonatal Phototherapy Units Sales 2021–2032
1.4.3 Global Neonatal Phototherapy Units Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Neonatal Phototherapy Units Market Competition by Manufacturers
2.1 Global Neonatal Phototherapy Units Sales Market Share by Manufacturers (2021–2026)
2.2 Global Neonatal Phototherapy Units Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Neonatal Phototherapy Units Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Neonatal Phototherapy Units, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Neonatal Phototherapy Units, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Neonatal Phototherapy Units, Product Types and Applications
2.7 Global Key Manufacturers of Neonatal Phototherapy Units, Date of Entry into the Industry
2.8 Global Neonatal Phototherapy Units Market Competitive Situation and Trends
2.8.1 Global Neonatal Phototherapy Units Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Neonatal Phototherapy Units Players Market Share by Revenue
2.8.3 Global Neonatal Phototherapy Units Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Neonatal Phototherapy Units Market Scenario by Region
3.1 Global Neonatal Phototherapy Units Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Neonatal Phototherapy Units Sales by Region: 2021–2032
3.2.1 Global Neonatal Phototherapy Units Sales by Region: 2021–2026
3.2.2 Global Neonatal Phototherapy Units Sales by Region: 2027–2032
3.3 Global Neonatal Phototherapy Units Revenue by Region: 2021–2032
3.3.1 Global Neonatal Phototherapy Units Revenue by Region: 2021–2026
3.3.2 Global Neonatal Phototherapy Units Revenue by Region: 2027–2032
3.4 North America Neonatal Phototherapy Units Market Facts & Figures by Country
3.4.1 North America Neonatal Phototherapy Units Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Neonatal Phototherapy Units Sales by Country (2021–2032)
3.4.3 North America Neonatal Phototherapy Units Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Neonatal Phototherapy Units Market Facts & Figures by Country
3.5.1 Europe Neonatal Phototherapy Units Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Neonatal Phototherapy Units Sales by Country (2021–2032)
3.5.3 Europe Neonatal Phototherapy Units Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neonatal Phototherapy Units Market Facts & Figures by Region
3.6.1 Asia Pacific Neonatal Phototherapy Units Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Neonatal Phototherapy Units Sales by Region (2021–2032)
3.6.3 Asia Pacific Neonatal Phototherapy Units Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Neonatal Phototherapy Units Market Facts & Figures by Country
3.7.1 Latin America Neonatal Phototherapy Units Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Neonatal Phototherapy Units Sales by Country (2021–2032)
3.7.3 Latin America Neonatal Phototherapy Units Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neonatal Phototherapy Units Market Facts & Figures by Country
3.8.1 Middle East and Africa Neonatal Phototherapy Units Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Neonatal Phototherapy Units Sales by Country (2021–2032)
3.8.3 Middle East and Africa Neonatal Phototherapy Units Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neonatal Phototherapy Units Sales by Type (2021–2032)
4.1.1 Global Neonatal Phototherapy Units Sales by Type (2021–2026)
4.1.2 Global Neonatal Phototherapy Units Sales by Type (2027–2032)
4.1.3 Global Neonatal Phototherapy Units Sales Market Share by Type (2021–2032)
4.2 Global Neonatal Phototherapy Units Revenue by Type (2021–2032)
4.2.1 Global Neonatal Phototherapy Units Revenue by Type (2021–2026)
4.2.2 Global Neonatal Phototherapy Units Revenue by Type (2027–2032)
4.2.3 Global Neonatal Phototherapy Units Revenue Market Share by Type (2021–2032)
4.3 Global Neonatal Phototherapy Units Price by Type (2021–2032)
5 Segment by Application
5.1 Global Neonatal Phototherapy Units Sales by Application (2021–2032)
5.1.1 Global Neonatal Phototherapy Units Sales by Application (2021–2026)
5.1.2 Global Neonatal Phototherapy Units Sales by Application (2027–2032)
5.1.3 Global Neonatal Phototherapy Units Sales Market Share by Application (2021–2032)
5.2 Global Neonatal Phototherapy Units Revenue by Application (2021–2032)
5.2.1 Global Neonatal Phototherapy Units Revenue by Application (2021–2026)
5.2.2 Global Neonatal Phototherapy Units Revenue by Application (2027–2032)
5.2.3 Global Neonatal Phototherapy Units Revenue Market Share by Application (2021–2032)
5.3 Global Neonatal Phototherapy Units Price by Application (2021–2032)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Company Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Neonatal Phototherapy Units Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 GE Healthcare Neonatal Phototherapy Units Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 Weyer GmbH
6.2.1 Weyer GmbH Company Information
6.2.2 Weyer GmbH Description and Business Overview
6.2.3 Weyer GmbH Neonatal Phototherapy Units Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Weyer GmbH Neonatal Phototherapy Units Product Portfolio
6.2.5 Weyer GmbH Recent Developments/Updates
6.3 Delta Medical International
6.3.1 Delta Medical International Company Information
6.3.2 Delta Medical International Description and Business Overview
6.3.3 Delta Medical International Neonatal Phototherapy Units Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Delta Medical International Neonatal Phototherapy Units Product Portfolio
6.3.5 Delta Medical International Recent Developments/Updates
6.4 Natus Medical Incorporated
6.4.1 Natus Medical Incorporated Company Information
6.4.2 Natus Medical Incorporated Description and Business Overview
6.4.3 Natus Medical Incorporated Neonatal Phototherapy Units Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Natus Medical Incorporated Neonatal Phototherapy Units Product Portfolio
6.4.5 Natus Medical Incorporated Recent Developments/Updates
6.5 Medicor
6.5.1 Medicor Company Information
6.5.2 Medicor Description and Business Overview
6.5.3 Medicor Neonatal Phototherapy Units Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Medicor Neonatal Phototherapy Units Product Portfolio
6.5.5 Medicor Recent Developments/Updates
6.6 Drager
6.6.1 Drager Company Information
6.6.2 Drager Description and Business Overview
6.6.3 Drager Neonatal Phototherapy Units Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Drager Neonatal Phototherapy Units Product Portfolio
6.6.5 Drager Recent Developments/Updates
6.7 Zeal Medical
6.7.1 Zeal Medical Company Information
6.7.2 Zeal Medical Description and Business Overview
6.7.3 Zeal Medical Neonatal Phototherapy Units Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Zeal Medical Neonatal Phototherapy Units Product Portfolio
6.7.5 Zeal Medical Recent Developments/Updates
6.8 MTTS
6.8.1 MTTS Company Information
6.8.2 MTTS Description and Business Overview
6.8.3 MTTS Neonatal Phototherapy Units Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 MTTS Neonatal Phototherapy Units Product Portfolio
6.8.5 MTTS Recent Developments/Updates
6.9 David Medical Device
6.9.1 David Medical Device Company Information
6.9.2 David Medical Device Description and Business Overview
6.9.3 David Medical Device Neonatal Phototherapy Units Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 David Medical Device Neonatal Phototherapy Units Product Portfolio
6.9.5 David Medical Device Recent Developments/Updates
6.10 BEING MEDICAL DEVICE
6.10.1 BEING MEDICAL DEVICE Company Information
6.10.2 BEING MEDICAL DEVICE Description and Business Overview
6.10.3 BEING MEDICAL DEVICE Neonatal Phototherapy Units Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 BEING MEDICAL DEVICE Neonatal Phototherapy Units Product Portfolio
6.10.5 BEING MEDICAL DEVICE Recent Developments/Updates
6.11 BIOBASE
6.11.1 BIOBASE Company Information
6.11.2 BIOBASE Description and Business Overview
6.11.3 BIOBASE Neonatal Phototherapy Units Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 BIOBASE Neonatal Phototherapy Units Product Portfolio
6.11.5 BIOBASE Recent Developments/Updates
6.12 Julongsanyou Technology
6.12.1 Julongsanyou Technology Company Information
6.12.2 Julongsanyou Technology Description and Business Overview
6.12.3 Julongsanyou Technology Neonatal Phototherapy Units Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Julongsanyou Technology Neonatal Phototherapy Units Product Portfolio
6.12.5 Julongsanyou Technology Recent Developments/Updates
6.13 Phoenix Medical Systems
6.13.1 Phoenix Medical Systems Company Information
6.13.2 Phoenix Medical Systems Description and Business Overview
6.13.3 Phoenix Medical Systems Neonatal Phototherapy Units Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Phoenix Medical Systems Neonatal Phototherapy Units Product Portfolio
6.13.5 Phoenix Medical Systems Recent Developments/Updates
6.14 Ibis Medical
6.14.1 Ibis Medical Company Information
6.14.2 Ibis Medical Description and Business Overview
6.14.3 Ibis Medical Neonatal Phototherapy Units Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Ibis Medical Neonatal Phototherapy Units Product Portfolio
6.14.5 Ibis Medical Recent Developments/Updates
6.15 Apothecaries Sundries Manufacturing
6.15.1 Apothecaries Sundries Manufacturing Company Information
6.15.2 Apothecaries Sundries Manufacturing Description and Business Overview
6.15.3 Apothecaries Sundries Manufacturing Neonatal Phototherapy Units Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Apothecaries Sundries Manufacturing Neonatal Phototherapy Units Product Portfolio
6.15.5 Apothecaries Sundries Manufacturing Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neonatal Phototherapy Units Industry Chain Analysis
7.2 Neonatal Phototherapy Units Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neonatal Phototherapy Units Production Mode & Process Analysis
7.4 Neonatal Phototherapy Units Sales and Marketing
7.4.1 Neonatal Phototherapy Units Sales Channels
7.4.2 Neonatal Phototherapy Units Distributors
7.5 Neonatal Phototherapy Units Customer Analysis
8 Neonatal Phototherapy Units Market Dynamics
8.1 Neonatal Phototherapy Units Industry Trends
8.2 Neonatal Phototherapy Units Market Drivers
8.3 Neonatal Phototherapy Units Market Challenges
8.4 Neonatal Phototherapy Units Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Neonatal Phototherapy Units was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 142
USD 3950.00
(Single User License)
The global Neonatal Phototherapy Units market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 99
USD 4250.00
(Single User License)
The global Neonatal Phototherapy Units market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 162
USD 4900.00
(Single User License)
The global market for Neonatal Phototherapy Units was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 129
USD 3950.00
(Single User License)
The global market for Neonatal Phototherapy Units was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 94
USD 2900.00
(Single User License)
Jaundice (Hyperbilirubinemia) is a common condition, particularly in pre-mature babies worldwide. The skin of the newborn baby becomes jaundiced (baby’s skin and Sclerae appear yellow) which is caused by a high level of bilirubin in the blood. Bilirubin is a waste product, produced when red blood cells are broken down. It is normally broken down in the liver and removed from the body in the stool. However, an underdeveloped liver of infant cannot filter out the bilirubin as fast as it i being produced, resulting in hyperbilirubinemia (Jaundice). If untreated the levels of bilirubin may rise high enough to pass through the blood brain barrier and is deposited in the brain causing Kernicterus and brain damage. Phototherapy is a treatment with special type of light (wavelength range 420 to 480nm) which lower bilirubin level in neonatal, the process is called photo-oxidation in which light wave converts the bilirubin to water soluble non-toxic form, make it easier for baby’s liver to break down and remove the bilirubin from their blood.
Published Date: 2024-01-17
Pages: 99
USD 2900.00
(Single User License)
The global market for Neonatal Phototherapy Units was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 142
The global Neonatal Phototherapy Units market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 99
The global Neonatal Phototherapy Units market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 162
The global market for Neonatal Phototherapy Units was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 129
The global market for Neonatal Phototherapy Units was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 94
Jaundice (Hyperbilirubinemia) is a common condition, particularly in pre-mature babies worldwide. The skin of the newborn baby becomes jaundiced (baby’s skin and Sclerae appear yellow) which is caused by a high level of bilirubin in the blood. Bilirubin is a waste product, produced when red blood cells are broken down. It is normally broken down in the liver and removed from the body in the stool. However, an underdeveloped liver of infant cannot filter out the bilirubin as fast as it i being produced, resulting in hyperbilirubinemia (Jaundice). If untreated the levels of bilirubin may rise high enough to pass through the blood brain barrier and is deposited in the brain causing Kernicterus and brain damage. Phototherapy is a treatment with special type of light (wavelength range 420 to 480nm) which lower bilirubin level in neonatal, the process is called photo-oxidation in which light wave converts the bilirubin to water soluble non-toxic form, make it easier for baby’s liver to break down and remove the bilirubin from their blood.
Published: 2024-01-17
Pages: 99
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now